Intriguingly, although NPC53 was identified with genetic mutations in CYLD and TRAF3, which is a genetic signature for EBV+ve NPC, the transcriptome profile of NPC53 revealed an inactivated NF-κB signaling and clustered with HK1 and NPC38. This evidence concerns the gene TRAF3 and nasopharyngeal carcinoma.